Literature DB >> 1553490

Chronic methamphetamine intoxication model of schizophrenia in animals.

Y Machiyama1.   

Abstract

The chronic methamphetamine (MAP) intoxication model of schizophrenia in animals is outlined. The idea originated from the clinical and neurochemical similarities between MAP psychosis and schizophrenia that were found during the decade immediately after World War II when MAP abuse occurred in epidemic proportions in Japan. The chronic intoxication model is produced by daily injections of a small dose of MAP into animals for several weeks or months. Behavioral studies with various species of animals from guinea pigs to monkeys produced essentially the same disorders as those observed in human abusers. Specifically, monkeys manifest psychotic behaviors, which appear to result from perceptual-cognitive disturbances, as well as enduring autistic behavior disorders that resemble the defect symptoms in chronic schizophrenia. Furthermore, the psychotic behaviors were found to have a high relapse liability; they recurred readily after the readministration of the drug or under nonspecific stress conditions. The difference and relationship between the chronic MAP intoxication model and the amphetamine stereotypy (acute intoxication) model are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1553490     DOI: 10.1093/schbul/18.1.107

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  10 in total

1.  MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens.

Authors:  Maw Shin Sim; Tomoko Soga; Vijayapandi Pandy; Yuan Seng Wu; Ishwar S Parhar; Zahurin Mohamed
Journal:  Metab Brain Dis       Date:  2017-07-05       Impact factor: 3.584

2.  Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.

Authors:  Masashi Ikeda; Yuko Okahisa; Branko Aleksic; Mujun Won; Naoki Kondo; Nobuya Naruse; Kumi Aoyama-Uehara; Ichiro Sora; Masaomi Iyo; Ryota Hashimoto; Yoshiya Kawamura; Nao Nishida; Taku Miyagawa; Masatoshi Takeda; Tsukasa Sasaki; Katsushi Tokunaga; Norio Ozaki; Hiroshi Ujike; Nakao Iwata
Journal:  Neuropsychopharmacology       Date:  2013-04-12       Impact factor: 7.853

Review 3.  Methamphetamine-associated psychosis.

Authors:  Kathleen M Grant; Tricia D LeVan; Sandra M Wells; Ming Li; Scott F Stoltenberg; Howard E Gendelman; Gustavo Carlo; Rick A Bevins
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-05       Impact factor: 4.147

4.  Extinction-dependent alterations in corticostriatal mGluR2/3 and mGluR7 receptors following chronic methamphetamine self-administration in rats.

Authors:  Marek Schwendt; Carmela M Reichel; Ronald E See
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

5.  Long-term effects of a single adult methamphetamine challenge: minor impact on dopamine fibre density in limbic brain areas of gerbils.

Authors:  Susanne Brummelte; Thorsten Grund; Andrea Czok; Gertraud Teuchert-Noodt; Jörg Neddens
Journal:  Behav Brain Funct       Date:  2006-03-28       Impact factor: 3.759

6.  Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compound.

Authors:  James B Thomas; Angela M Giddings; Robert W Wiethe; Srinivas Olepu; Keith R Warner; Philippe Sarret; Louis Gendron; Jean-Michel Longpre; Yanan Zhang; Scott P Runyon; Brian P Gilmour
Journal:  J Med Chem       Date:  2014-06-05       Impact factor: 7.446

7.  A Markerless 3D Computerized Motion Capture System Incorporating a Skeleton Model for Monkeys.

Authors:  Tomoya Nakamura; Jumpei Matsumoto; Hiroshi Nishimaru; Rafael Vieira Bretas; Yusaku Takamura; Etsuro Hori; Taketoshi Ono; Hisao Nishijo
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

8.  Altered Fecal Microbiota Correlated With Systemic Inflammation in Male Subjects With Methamphetamine Use Disorder.

Authors:  Di Deng; Hang Su; Yuehong Song; Tianzhen Chen; Qianqian Sun; Haifeng Jiang; Min Zhao
Journal:  Front Cell Infect Microbiol       Date:  2021-11-18       Impact factor: 5.293

Review 9.  The neurobiology of methamphetamine induced psychosis.

Authors:  Jennifer H Hsieh; Dan J Stein; Fleur M Howells
Journal:  Front Hum Neurosci       Date:  2014-07-22       Impact factor: 3.169

10.  Decreased DNA Methylation in the Shati/Nat8l Promoter in Both Patients with Schizophrenia and a Methamphetamine-Induced Murine Model of Schizophrenia-Like Phenotype.

Authors:  Kyosuke Uno; Yuu Kikuchi; Mina Iwata; Takashi Uehara; Tadasu Matsuoka; Tomiki Sumiyoshi; Yoshinori Okamoto; Hideto Jinno; Tatsuyuki Takada; Yoko Furukawa-Hibi; Toshitaka Nabeshima; Yoshiaki Miyamoto; Atsumi Nitta
Journal:  PLoS One       Date:  2016-06-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.